Talis Biomedical Co. (NASDAQ:TLIS – Get Free Report) was up 77.5% on Friday . The stock traded as high as $2.84 and last traded at $2.84. Approximately 59,306 shares changed hands during trading, an increase of 2,761% from the average daily volume of 2,073 shares. The stock had previously closed at $1.60.
Talis Biomedical Price Performance
The company has a market capitalization of $5.18 million, a P/E ratio of -0.10 and a beta of 1.32. The business has a 50-day moving average of $2.02 and a 200-day moving average of $1.67.
About Talis Biomedical
Talis Biomedical Corp is a molecular diagnostics company that develops point-of-care testing solutions for infectious diseases. The company’s technology leverages sample-to-answer automation to deliver rapid, lab-quality results outside of traditional laboratory settings. Talis Biomedical focuses on simplifying complex molecular assays to enable broader access in clinical laboratories, urgent care facilities and other decentralized testing environments.
The company’s flagship Talis One platform integrates proprietary reagents, single-use test cartridges and a compact analyzer to automate the workflow from extracted sample to result.
See Also
- Five stocks we like better than Talis Biomedical
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- Do not delete, read immediately
- A U.S. “birthright” claim worth trillions – activated quietly
- First Time Since 2007: All Warnings Active
- Best $19 you’ll spend this year.
Receive News & Ratings for Talis Biomedical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Talis Biomedical and related companies with MarketBeat.com's FREE daily email newsletter.
